Ensemble VC — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Neion Bio operates a biomanufacturing platform that re-engineers eggs into living bioreactors using genetic engineering and stem cell biology to produce biological molecules such as monoclonal antibodies, enzymes, fusion proteins, peptides, and cytokines.
Advanced ManufacturingBiotechDeep TechNew York, US
Sam Levin(Founder)inDimi Kellari(Founder)in
Co-investorsCaffeinated CapitalClocktower VenturesHAWKTAILBasis Set VenturesDigitalis VenturesHaystack+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





